Samsara Crosses $2.1 Billion ARR, Beats Expectations on Enterprise and AI Momentum
Samsara beat Q2 estimates with $508.4M revenue and $0.20 EPS, then raised FY2027 guidance as large customers and new AI features accelerated.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Samsara beat Q2 estimates with $508.4M revenue and $0.20 EPS, then raised FY2027 guidance as large customers and new AI features accelerated.
Q4 revenue and EPS beat estimates, but Guidewire’s $372–$378 million Q1 sales guide trailed Wall Street and weighed on the stock.
The move targets growing AI infrastructure needs with advanced power conversion and 800V systems.
Q2 revenue jumped 58% to a record $116.1 million. Cash hit $865 million. Q3 sales guidance of $101–105 million is a sequential step-down.
Docusign beat Q2 estimates and raised FY27 guidance as IAM reached 15.1% of ARR. Margins and free cash flow also topped expectations.
Lululemon Q2 sales fell 4% to $2.42B, missing estimates. Full-year forecast cut to $10.35–$10.50B as new CEO Heidi O’Neill takes over next week.